U.S. Markets closed

Will This Beaten-Down Stock Bounce Back? 3 Things to Know

·4 min read
Will This Beaten-Down Stock Bounce Back? 3 Things to Know
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Vertex Pharmaceuticals (NASDAQ: VRTX) has given more than one investor a headache over the past year. Investors worry that Vertex is struggling to expand beyond its core portfolio of cystic fibrosis (CF) treatments. Considering the time Vertex shares have spent in the doldrums, you may be getting a little impatient.